04.01.2017 20:00:52
|
Ocular Therapeutix Pulls Back Off Early Highs But Remains Positive
(RTTNews) - After moving sharply higher in early trading on Wednesday, shares of Ocular Therapeutix (OCUL) have given back some ground but remain positive. Ocular is currently up by 4.3 percent.
The initial jump by Ocular came after the biopharmaceutical company announced additional positive secondary endpoint results from its phase 3 clinical trial of Dextenza for the treatment of post-surgical ocular inflammation and pain.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Ocular Therapeutix Incmehr Nachrichten
13.11.24 |
Ausblick: Ocular Therapeutix verkündet Quartalsergebnis zum jüngsten Jahresviertel (finanzen.net) |
Analysen zu Ocular Therapeutix Incmehr Analysen
Aktien in diesem Artikel
Ocular Therapeutix Inc | 6,75 | -2,71% |
|